Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04193553
Title Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure (LENVAGIST)
Acronym LENVAGIST
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Leon Berard
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Centre Antoine LACASSAGNE Nice Alpes-Maritimes 06189 France Details
Hopital de La Timone Marseille Bouches Du Rhône 13385 France Details
Institut Paoli Calmette Marseille Bouches-du-Rhône 13273 France Details
Centre Georges-François Leclerc Dijon Bourgogne-Franche-Comté 21079 France Details
Institut Bergonié Bordeaux Gironde 33076 France Details
Institut Universitaire du Cancer de Toulouse Oncopole Toulouse Haute-Garonne 31059 France Details
Centre Oscar LAMBRET Lille Hauts-de-France 59020 France Details
Centre Eugène Marquis Rennes Ille-et-Vilaine 44229 France Details
ICO Centre René Gauducheau Saint-Herblain Loire-Atlantique 44805 France Details
CHU de Reims Reims Marne 51000 France Details
Institut de Cancérologie de Lorraine Alexis Vautrin Vandœuvre-lès-Nancy Meurthe-et-Moselle 54511 France Details
Centre Léon Bérard Lyon Rhône 69373 France Details
Institut Gustave Roussy Villejuif Val-de-Marne 94805 France Details
CHU Poitiers Poitiers Vienne 86021 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field